Short term effects of sildenafil citrate therapy in secondary pulmonary hypertension

Short term effects of sildenafil citrate therapy in secondary pulmonary hypertension

Objectives: To study the short term effects of sildenafil citrate therapy in patients with secondary pulmonary hypertension. Methods: Forty patients with known symptomatic secondary pulmonary hypertension due to valvular heart disease, chronic thromboembolic disease, chronic obstructive pulmonary di...

Full description

Bibliographic Details
Main Authors:	Mohamed Salem, Ahmed Diab, Ali Ateya, Osama Sanad
Format:	Article
Language:	English
Published:	SpringerOpen 2014-03-01
Series:	The Egyptian Heart Journal
Subjects:	Sildenafil Pulmonary hypertension Echocardiography
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110260813000240

Similar Items

Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease
by: Khaled Alkhayat, et al.
Published: (2016-10-01)

Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure
by: Kinjal Desai, et al.
Published: (2023-01-01)

Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
by: Chinmay Chetan, et al.
Published: (2022-05-01)

Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia – a case report
by: Karen Lavie-Nevo, et al.
Published: (2019-11-01)

Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil for pulmonary hypertension treatment after cardiac surgery
by: Maria Regina Bentlin, et al.
Published: (2005-04-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01)

Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension
by: Michele Correale, et al.
Published: (2015-12-01)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023-08-01)

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
by: Stephanie Leigh Siehr, et al.
Published: (2015-03-01)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
by: Maurice Beghetti, et al.
Published: (2017-07-01)

Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report
by: Olapeju Daniyan, et al.
Published: (2022-06-01)

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

Sildenafil in Infants and Children
by: Larisa Simonca, et al.
Published: (2017-07-01)

The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
by: Z Kh Dadacheva, et al.
Published: (2015-09-01)

The role of sildenafil in perioperative management of patients with pulmonary hypertension undergoing lower limb vascular surgery
by: Ashraf A.H M. Soliman, et al.
Published: (2022-01-01)

Appropriateness of Sildenafil Prescribing in Pulmonary Hypertension with Valvular Heart Disease: A Single Centre Study
by: Tze Hoon Goo, et al.
Published: (2022-03-01)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
by: Oktavia Lilyasari, et al.
Published: (2019-08-01)

The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension
by: Galina A. Alyamovskaya, et al.
Published: (2015-02-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
by: Enhuan Wei, et al.
Published: (2023-11-01)

Comparison of the Efficacy of Milrinone Injection versus Milrinone Plus Oral Sildenafil in Newborns with Pulmonary Arterial Hypertension
by: Mohammad Mehdi Bagheri, et al.
Published: (2021-01-01)

One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01)

The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects
by: Hamid Bigdelian, et al.
Published: (2017-09-01)

Sildenafil for pulmonary hypertension due to left-toright shunt after corrective procedure
by: Dyahris Kuntartiwi, et al.
Published: (2015-09-01)

Evaluation of Addition Of Sildenafil Citrate On Fetal Growth And Doppler Indices In Treatment of Pregnancy Induced Hypertension
by: Eman Farid, et al.
Published: (2022-01-01)

The Impact of Combined Oral Sildenafil and Inhaled Nitric Oxide for Treating Persistent Pulmonary Hypertension of the Newborn: A Single Center Experience
by: Hayriye Gozde Kanmaz, et al.
Published: (2017-08-01)

Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials
by: Ahmed K. Awad, et al.
Published: (2023-07-01)

Sildenafil prevents the increase of extravascular lung water and pulmonary hypertension after meconium aspiration in newborn piglets
by: F.E. Silvera, et al.
Published: (2011-08-01)

Sildenafil prevents the increase of extravascular lung water and pulmonary hypertension after meconium aspiration in newborn piglets
by: F.E. Silvera, et al.
Published: (2011-08-01)

Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil analogue (UK343-664) or nitroglycerin
by: Sidi Avner, et al.
Published: (2008-01-01)

Sildenafil prevents right ventricular hypertrophy and improves heart rate variability in rats with pulmonary hypertension secondary to experimental diabetes
by: Miguel Angel Garcia-Gonzalez, et al.
Published: (2022-05-01)

Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats
by: Shiho Yoshida, et al.
Published: (2023-07-01)

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
by: Shine Kumar, et al.
Published: (2022-10-01)

Comparative therapeutic effect of the L-arginine and sildenafil on beta-thalassemia children with increased tricuspid regurgitant jet velocity
by: Hosny Mohammed Ahmed El-Masry, et al.
Published: (2020-06-01)

Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis
by: Linli Sun, et al.
Published: (2021-09-01)

Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
by: A V Volkov, et al.
Published: (2015-11-01)

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation
by: Y-F Chen, et al.
Published: (2009-10-01)

Sildenafil Citrate Liposomes for Pulmonary Delivery by Ultrasonic Nebulization
by: María José de Jesús Valle, et al.
Published: (2018-08-01)

The management of adult female patients with Eisenmenger syndrome and advanced pulmonary arterial hypertension treatment: single center experience and follow-up for 5 years
by: Gülten Taçoy, et al.
Published: (2014-09-01)